APA (7th ed.) Citation

W, L., Y, M., X, Z., Y, W., J, W., S, Z., . . . M, Z. (2019). RGDV-modified gemcitabine: A nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine. Dove Medical Press.

Chicago Style (17th ed.) Citation

W, Liu, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, and Zhao M. RGDV-modified Gemcitabine: A Nano-medicine Capable of Prolonging Half-life, Overcoming Resistance and Eliminating Bone Marrow Toxicity of Gemcitabine. Dove Medical Press, 2019.

MLA (8th ed.) Citation

W, Liu, et al. RGDV-modified Gemcitabine: A Nano-medicine Capable of Prolonging Half-life, Overcoming Resistance and Eliminating Bone Marrow Toxicity of Gemcitabine. Dove Medical Press, 2019.